Business Standard



SEC asks J&J to monitor adverse events closely for next three months

SEC asks J&J to submit interim safety data after 28 days

J&J had expanded clinical trials of two-dose regimen to adolescent­s in

April globally Company is testing a two-dose regimen globally

 ?? ??

Newspapers in English

Newspapers from India